Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K/AKT signaling pathway.
Saved in:
| Title: | Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K/AKT signaling pathway. |
|---|---|
| Authors: | Aierken, Aili1 (AUTHOR), Li, Balun1 (AUTHOR), Liu, Peng2 (AUTHOR), Cheng, Xuedi1 (AUTHOR), Kou, Zheng1 (AUTHOR), Tan, Ning1 (AUTHOR), Zhang, Mengfei1 (AUTHOR), Yu, Shuai1 (AUTHOR), Shen, Qiaoyan1 (AUTHOR), Du, Xiaomin1 (AUTHOR), Enkhbaatar, Bold Bayar1 (AUTHOR), Zhang, Juqing1 (AUTHOR), Zhang, Rui1 (AUTHOR), Wu, Xiaolong1 (AUTHOR), Wang, Ruibin1 (AUTHOR), He, Xin1 (AUTHOR), Li, Na1 (AUTHOR), Peng, Sha1 (AUTHOR), Jia, Wenwen3 (AUTHOR) wuj3@tongji.edu.cn, Wang, Congrong4 (AUTHOR) crwang@tongji.edu.cn |
| Source: | Stem Cell Research & Therapy. 4/12/2022, Vol. 13 Issue 1, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
